Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study
NCT03737435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-09-22
Summary
International, multicenter retrospecitve biological study
Conditions
- Localized Osteosarcoma
Sponsors & Collaborators
-
Istituto Ortopedico Rizzoli
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-12
- Primary Completion
- 2024-10-25
- Completion
- 2024-10-25
Countries
- Italy
Study Locations
More Related Trials
-
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
NCT05585320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma
NCT04651179 ·Status: COMPLETED
-
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients
NCT05615883 ·Status: COMPLETED ·Phase: NA
-
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
NCT00656305 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib.
NCT03514901 ·Status: UNKNOWN ·Phase: PHASE2
-
Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
NCT05984615 ·Status: COMPLETED
-
Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
NCT00747825 ·Status: TERMINATED ·Phase: PHASE1
-
An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma
NCT02143999 ·Status: COMPLETED
-
Minimally Invasive Surgery (MIS) for Spine Metastases
NCT02367378 ·Status: COMPLETED
-
Open Label Extension In Cancer Patients
NCT00830180 ·Status: COMPLETED ·Phase: PHASE2
-
Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
NCT01359956 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases
NCT03625141 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
NCT00057616 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
NCT05374915 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
NCT02780089 ·Status: COMPLETED
-
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
NCT04132895 ·Status: RECRUITING
-
Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
NCT00055562 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)
NCT04547946 ·Status: COMPLETED
-
A Clinical Study of T3011 in Subjects With Advanced Melanoma
NCT06214156 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome
NCT00157274 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)
NCT01010672 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases
NCT04793737 ·Status: RECRUITING ·Phase: NA
-
Intratumoral Application of L19IL2 in Patients With Malignant Melanoma
NCT01253096 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)
NCT03534635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
NCT04216953 ·Status: COMPLETED ·Phase: PHASE1/PHASE2